Competitor Analysis Series

1. What is the Competitor Analysis Series?
2. What is the difference to other Competitive Intelligence products?
3. What kind of information is given in the Competitor Analysis reports?
4. Who is conducting the Competitor Evaluations?
5. What is R&D Pipeline News?
6. How many Competitor Analysis Reports will be published in a 1-year period?
7. Can you give me examples for past Competitor Analysis Reports?
8. What will be future topics of the Competitor Analysis Series?
9. How do I know about new reports from the Competitor Analysis Series?
10. How much does a single Competitor Analysis report cost?
11. How much does a 1-year subscription to R&D Pipeline News cost?
12. Can I subscribe for a shorter period?
13. How can I purchase a subscription?

---



1. - What is the Competitor Analysis Series?

Evaluations of competitor R&D projects for targets, diseases, product categories/technologies and of company pipelines published weekly in R&D Pipeline News and also available as single products



2.- What is the difference to other Competitive Intelligence products?

NO-FRILLS product at low prices, but with concise information provided in a tabular format and fully referenced to the source of information; at the time of publication fully updated with active projects only



3.- What kind of information is given in the Competitor Analysis reports?

The competitor R&D projects are listed in a table providing information about:

 

• Drug codes (generic and/or brand names);
• Target/mechanism of action;
• Class of compound;
• Company;
• Product category or therapeutic area or territory;
• Indication;
• R&D stage (phase);
• Additional comments and/or a hyperlink leading to the source of information.



 

4.- Who is conducting the Competitor Evaluations?

Independent research analysts from La Merie Business Intelligence with many years of experience in R&D and business development of the biopharmaceutical industry



5.- What is R&D Pipeline News?

A weekly publication from La Merie Business Intelligence in pdf-format delivered by e-mail directly to the desktop of the subscriber and providing information in tabular format about :
• Competitor Evaluation (Competitor Analysis Series);
• R&D News (press releasees about R&D projects);
• Corporate News (Collaborations, Licensing, Mergers & Acquisitions)



 

6.- How many Competitor Analysis Reports will be published in a 1-year period?

About 50 different competitor evaluations will be conducted and published in R&D Pipeline News, many of them will also be available as single products, but not all



7.- Can you give me examples for past Competitor Analysis Reports?

Biogenerics: EPO, G-CSF, hGH, Interferon

Diabetes: Insulin, DPP-IV, GLP-1, PPAR, SGLT, CB-1, emerging drugs in early development

Oncology: VEGF/R, Plk-1, PARP, B-RAF, Aurora Kinase, TPO, IGF-1R, EpCAM

Cardiovascular: VEGF Agonists, Thrombolytics

Inflammation: mTOR, PDE-4, TNF, S1P-R, syk kinase

Diseases: Psoriasis, wet AMD, Amyotrophic Lateral Sclerosis

 



8.- What will be future topics of the Competitor Analysis Series

The subjects of future competitor analyses will consider the relative proportion of therapeutic areas and of technologies, i.e. major therapeutic areas are oncology, neurology & psychiatry, infectious & toxicology, inflammation, cardiovascular and metabolism & endocrine; the weighting of the product categories/technologies will be about 40 % biologics (antibodies; proteins & peptides; Vaccines; DNA, RNA & Cells) and 60 % small molecules.



9.- How do I know about new reports from the Competitor Analysis Series?

By regular visits of our website, by subscribing to our New Product Release Alert or by subscribing to La Merie Daily Free Newsletter which also informs about new releases



10.- How much does a single Competitor Analysis report cost?

Prices for single Competitor Analysis reports range from € 50.- to € 300.- depending on the time and work invested and volume of the product. Compilations, e.g. Biogenerics, may cost more (e.g. € 800.-)



11.- How much does a 1-year subscription to R&D Pipeline News cost?

An individual, single subscription for 1 year costs € 600.- for 50 issues. Discounts of up to 80 % are applicable for multi-user subscriptions, e.g. for companies or other large organizations.



12.- Can I subscribe for a shorter period?

Yes, if you are interested to subscribe for a period shorter than 1 year, please This e-mail address is being protected from spam bots, you need JavaScript enabled to view it



13.- How can I purchase a subscription?

You can buy the subscription online via our secure purchase system or contact us via fax, e-mail or telephone and pay with credit card; we also accept payment by bank transfer in the case of companies, in case that you would like to order via fax, email or telephone please contact us first via This e-mail address is being protected from spam bots, you need JavaScript enabled to view it



14.- Can I evaluate R&D Pipeline News in a FREE Trial? .

Yes, we offer a 3-weeks FREE Trial